Analisis Weight Average Cost of Capital (WACC) Pada Perusahaan Sektor Healthcare

Indah Permatasari, Agus Munandar

Abstract


Tujuan Penelitian: Penelitian ini bertujuan untuk mengevaluasi efisiensi struktur modal perusahaan sektor healthcare yang terdaftar di Bursa Efek Indonesia (BEI) periode 2023–2024 dengan menggunakan pengukuran Weighted Average Cost of Capital (WACC), sebagai respons atas tingginya sensitivitas terhadap biaya modal, terutama pada periode pascapandemi ketika kebijakan moneter dan fluktuasi suku bunga memengaruhi keputusan pendanaan perusahaan.

Metode Penelitian: Penelitian ini menggunakan pendekatan kuantitatif deskriptif dengan data sekunder berupa laporan keuangan tahunan. Variabel yang dianalisis meliputi cost of debt, cost of equity, dan WACC.

Originalitas/Novelty: Kebaruan penelitian terletak pada pengukuran WACC tingkat perusahaan (firm-level) di sektor healthcare serta pengelompokan perusahaan ke dalam kategori Low WACC dan High WACC berbasis median tahunan, dengan mempertimbangkan faktor internal perusahaan dan dinamika kebijakan moneter pascapandemi.

Hasil Penelitian: Perusahaan dengan kategori Low WACC cenderung memiliki struktur pendanaan yang lebih seimbang serta pengelolaan biaya utang yang lebih efisien. Sebaliknya, perusahaan dengan High WACC menunjukkan ketergantungan yang lebih besar pada sumber pendanaan berbiaya tinggi.

Implikasi: Temuan ini menegaskan pentingnya efisiensi struktur modal dalam menekan biaya modal perusahaan. Implikasi penelitian ini relevan bagi manajemen, investor, dan regulator dalam pengambilan keputusan pembiayaan dan investasi di sektor healthcare.

 

Research Objectives: This study evaluates the capital structure efficiency of healthcare companies listed on the Indonesia Stock Exchange (IDX) during 2023–2024 using the Weighted Average Cost of Capital (WACC), in response to the sector’s high sensitivity to capital costs, particularly in the post-pandemic period when monetary policy and interest rate fluctuations influence corporate financing decisions.

Research Method: A descriptive quantitative approach is employed using secondary data from annual financial statements. The analysis focuses on the cost of debt, cost of equity, and WACC.

Originality/Novelty: The novelty of this study lies in the measurement of firm-level WACC in the healthcare sector and the categorization of companies into Low WACC and High WACC categories based on annual medians, taking into account internal company factors and post-pandemic monetary policy dynamic

Research Results: The results indicate that companies categorized as Low WACC tend to exhibit a more balanced financing structure and more efficient debt cost management. In contrast, High WACC firms demonstrate a greater reliance on high-cost financing sources. These findings underscore the importance of capital structure efficiency in reducing a firm’s overall cost of capital.

Implications: The implications of this study are relevant for corporate management, investors, and regulators in making financing and investment decisions within the healthcare sector.


Keywords


WACC, Cost of Debt, Cost of Equity, Healthcare Sector

Full Text:

PDF

References


Arofah, U., Hakim, M. S., & Alfarizi, M. (2025). Capital efficiency and organizational performance: A dynamic panel analysis of weighted average cost of capital (WACC) and ROA in Indonesia’s healthcare sector. Journal of Applied Sciences in Accounting, Finance and Tax, 8(1), 26–40.

Brigham, E. F., & Houston, J. F. (2022). Fundamentals of financial management (16th ed.). Cengage Learning.

BRI Danareksa Sekuritas. (2024, March 13). Healthcare sector update: On track 4Q23 operational affirm attractive growth and return outlook. Equity research report.

Zuniga-Jara, S., Ruiz-Campo, S., & Soria-Barreto, K. (2025). A heuristic model for the cost of capital of healthcare facilities: Estimates for five countries. BMC Health Services Research, 25, 1242.

Karini. (2025). Manajemen keuangan lanjutan. CV Graha Ilmu.

Kementerian Keuangan Republik Indonesia. (2021). Health sector final sector review report. Directorate of Government Support and Infrastructure Financing Management (DGSIFM).

https://www.kemenkeu.go.id

Lazard. (2024, February). Lazard healthcare services leaders study 2024: Executive summary. Lazard Ltd.

https://www.lazard.com/insights/healthcare-services-leaders-study-2024

Li, Y. (2023). Research on capital structure and investment value of the healthcare industry. In Proceedings of the 7th International Conference on Economic Management and Green Development

Miao, Y., & Zhong, L. (2024). Corporate financing efficiency in healthcare companies: Evidence from global pharmaceutical firms. Journal of Finance and Healthcare Management, 6(2), 112–130.

Myers, S. C., & Majluf, N. S. (1984). Corporate financing and investment decisions when firms have information that investors do not have. Journal of Financial Economics, 13(2), 187–221.

Natasha, D., Rachmawati, A., & Yuliah, S. (2025). Cost of capital and investment decision in Indonesian healthcare industry: Post-pandemic evidence. Indonesian Journal of Financial Studies, 4(1), 51–66.

Reza, N., & Heikal, J. (2024). Evaluating ideal capital structure through WACC and ROA analysis: Research on IDX-listed Indonesian drug retailers and distributors (2019–2023). International Journal of Scientific Research and Management, 12(7), 6872–6881.

World Bank Group. (2025). Low-income countries spend just $17 per capita annually on health.

https://www.worldbank.org/en/news

World Health Organization. (2026). Indonesia health accounts 2024: Strengthening evidence for health financing. https://www.who.int/publications




DOI: https://doi.org/10.30596/jakk.v9i1.27577

Refbacks

  • There are currently no refbacks.